Indian Drugmaker Taps Private Credit for Japanese Acquisition
Indian drugmaker Gujarat Themis Biosyn Ltd. has obtained private credit funding to back its purchase of Japanese peer MicroBiopharm Japan Co., highlighting the growing use of such debt for overseas...
By Megawati Wijaya and Dipika Lalwani · Bloomberg Markets
Indian drugmaker Gujarat Themis Biosyn Ltd. has obtained private credit funding to back its purchase of Japanese peer MicroBiopharm Japan Co., highlighting the growing use of such debt for overseas expansion in Asia.